Alpha Cognition Inc...has been granted a new U.S. patent covering specific oral dosing methods for benzgalantamine in treating mild to moderate Alzheimer’s disease, the company announced Wednesday.

Zunveyl (benzgalantamine) - Alpha Cognition

Feb 18, 2026